Which of the following drug is commonly used in treatment for cancer associated thromboembotismt
High-Yield Explanation
Ans: A. Low molecular weight heparinCurrent guideline-endorsed therapy options for cancer-associated thrombosis include low molecularweight heparin (LMWH), unfractionated heparin (UFH), warfarin & fondaparinux.All current guidelines recommend LMWH for at least 3-6 months in cancer-associated VTE.